Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 5—May 2004

Research

Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients

Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*Comments to Author , and Pan-Chyr Yang*
Author affiliations: *National Taiwan University Hospital, Taipei, Taiwan

Main Article

Table 4

Complications found in 76 SARS patientsa

Complication No. of patients (%)
Rhabdomyolysis
4 (5.3)
Peripheral neuropathy
5 (6.6)
Acute renal failure
3 (3.9)
Gastrointestinal bleeding
2 (2.6)
Acute myocardial infarction
1 (1.3)
Bacteria superinfection
10 (13.2)
Candida parapsilosis superinfection
1 (1.3)
MRSA
4 (5.3)
MRSE
2 (2.6)
Enterococci
3 (3.9)
Acinetobacter baumannii
3 (3.9)
Klebsiella pneumoniae
2 (2.6)
Enterobacter cloacae
1 (1.3)
Serratia marcescense
1 (1.3)
Total 18 (23.7)

aSARS, severe acute respiratory syndrome; MRSA, methicillin-resistant Staphylococcus aureus; MRSE, methicillin-resistant Staphylococcus epidermidis. Some patients experience more than one complication.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO